标题
Key advances in vaccine development for tuberculosis—success and challenges
作者
关键词
-
出版物
npj Vaccines
Volume 8, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-13
DOI
10.1038/s41541-023-00750-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
- (2023) Sasha E. Larsen et al. Vaccines
- Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques
- (2023) Patricia A. Darrah et al. Cell Host & Microbe
- High Bacillary Burden and the ESX-1 Type VII Secretion System Promote MHC Class I Presentation by Mycobacterium tuberculosis–Infected Macrophages to CD8 T Cells
- (2023) Daniel Mott et al. JOURNAL OF IMMUNOLOGY
- BCG-induced trained immunity: history, mechanisms and potential applications
- (2023) Jingjing Chen et al. Journal of Translational Medicine
- Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
- (2023) Zachary K. Sagawa et al. Nature Communications
- A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity
- (2023) Wenchao Li et al. Cell Reports
- Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
- (2023) Sam Afkhami et al. npj Vaccines
- The Tuberculous Granuloma and Preexisting Immunity
- (2022) Sara B. Cohen et al. Annual Review of Immunology
- Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice
- (2022) Clare M Smith et al. eLife
- Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control
- (2022) Hannah P. Gideon et al. IMMUNITY
- Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
- (2022) Hazel M. Dockrell et al. EBioMedicine
- Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial
- (2022) Mark F Cotton et al. LANCET INFECTIOUS DISEASES
- Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
- (2022) Zhidong Hu et al. Frontiers in Immunology
- Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis
- (2022) Taru S. Dutt et al. Cell Reports
- A century of BCG: Impact on tuberculosis control and beyond*
- (2021) Asma Ahmed et al. IMMUNOLOGICAL REVIEWS
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- mRNA vaccines for infectious diseases: principles, delivery and clinical translation
- (2021) Namit Chaudhary et al. NATURE REVIEWS DRUG DISCOVERY
- Robust IgM responses following intravenous vaccination with Bacille Calmette–Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques
- (2021) Edward B. Irvine et al. NATURE IMMUNOLOGY
- A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
- (2021) Synne Jenum et al. Nature Communications
- Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
- (2021) Stefan H. E. Kaufmann Frontiers in Microbiology
- Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation
- (2021) Lucia Suarez-Lopez et al. iScience
- Prevention of tuberculosis in macaques after intravenous BCG immunization
- (2020) Patricia A. Darrah et al. NATURE
- β-Glucan Induces Protective Trained Immunity against Mycobacterium tuberculosis Infection: A Key Role for IL-1
- (2020) Simone J.C.F.M. Moorlag et al. Cell Reports
- The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection
- (2020) Sherry L. Kurtz et al. mSphere
- An interspecies translation model implicates integrin signaling in infliximab-resistant inflammatory bowel disease
- (2020) Douglas K. Brubaker et al. Science Signaling
- DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial
- (2020) Patricia Munseri et al. VACCINE
- A natural polymorphism of Mycobacterium tuberculosis in the esxH gene disrupts immunodomination by the TB10.4-specific CD8 T cell response
- (2020) Rujapak Sutiwisesak et al. PLoS Pathogens
- Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis
- (2020) Courtney R. Plumlee et al. Cell Host & Microbe
- Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
- (2020) Deepshikha Verma et al. Vaccines
- Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
- (2019) Karin Dijkman et al. NATURE MEDICINE
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
- (2019) Lenette L. Lu et al. NATURE MEDICINE
- Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation
- (2019) Sam Afkhami et al. JOURNAL OF INFECTIOUS DISEASES
- Three decades of messenger RNA vaccine development
- (2019) Rein Verbeke et al. Nano Today
- Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice
- (2019) Clare M. Smith et al. mBio
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
- (2018) Eva Kaufmann et al. CELL
- BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
- (2018) Rob J.W. Arts et al. Cell Host & Microbe
- Antibody-based vaccine strategies against intracellular pathogens
- (2018) Arturo Casadevall CURRENT OPINION IN IMMUNOLOGY
- Mycobacterial growth inhibition is associated with trained innate immunity
- (2018) Simone A. Joosten et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives
- (2018) Laurent Abel et al. LANCET INFECTIOUS DISEASES
- Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine
- (2018) Scott G Hansen et al. NATURE MEDICINE
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages
- (2018) Jason D. Yang et al. PLoS Pathogens
- Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878–1940
- (2018) P. R. Donald et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
- (2018) Elizabeth Whittaker et al. Scientific Reports
- Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity
- (2018) Yushi Yao et al. CELL
- A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
- (2018) Ali N. Kamali et al. MOLECULAR IMMUNOLOGY
- Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
- (2017) Lucy C. K. Bell et al. NATURE REVIEWS MICROBIOLOGY
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- A Functional Role for Antibodies in Tuberculosis
- (2016) Lenette L. Lu et al. CELL
- Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines
- (2016) Thomas J. Scriba et al. JOURNAL OF INFECTIOUS DISEASES
- Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
- (2016) Patrick Nguipdop-Djomo et al. LANCET INFECTIOUS DISEASES
- Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype
- (2016) Clare M. Smith et al. mBio
- T-cell activation is an immune correlate of risk in BCG vaccinated infants
- (2016) Helen A. Fletcher et al. Nature Communications
- CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
- (2016) Shunsuke Sakai et al. PLoS Pathogens
- Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection
- (2015) M Jeyanathan et al. Mucosal Immunology
- Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies
- (2015) Igor Kramnik et al. Seminars in Immunopathology
- The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3
- (2015) Gavin John Churchyard et al. VACCINE
- Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
- (2015) E. Stylianou et al. VACCINE
- Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization
- (2015) Hannah Priyadarshini Gideon et al. PLoS Pathogens
- BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
- (2014) Johanneke Kleinnijenhuis et al. CLINICAL IMMUNOLOGY
- Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
- (2014) I Abubakar et al. HEALTH TECHNOLOGY ASSESSMENT
- Protective CD4 T Cells Targeting Cryptic Epitopes of Mycobacterium tuberculosis Resist Infection-Driven Terminal Differentiation
- (2014) J. S. Woodworth et al. JOURNAL OF IMMUNOLOGY
- In search of a new paradigm for protective immunity to TB
- (2014) Cláudio Nunes-Alves et al. NATURE REVIEWS MICROBIOLOGY
- Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
- (2014) Andre S. Nell et al. PLoS One
- Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-γ immunity
- (2014) Jacinta Bustamante et al. SEMINARS IN IMMUNOLOGY
- Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
- (2014) Hazel C. Poyntz et al. TUBERCULOSIS
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Human Gene Variants Linked to Enhanced NLRP3 Activity Limit Intramacrophage Growth of Mycobacterium tuberculosis
- (2013) Daniel Eklund et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
- (2013) F. Smaill et al. Science Translational Medicine
- Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
- (2013) Ainhoa Arbues et al. VACCINE
- Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
- (2012) Emily R. Driver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The recombinant tuberculosis vaccine rBCG ΔureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells
- (2012) Maura Farinacci et al. VACCINE
- Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection
- (2011) Bisweswar Nandi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Macrophages Infected with a High Burden of ESAT-6-Expressing M. tuberculosis Undergo Caspase-1- and Cathepsin B-Independent Necrosis
- (2011) Amanda Welin et al. PLoS One
- Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4–HspX
- (2011) Hongxia Niu et al. VACCINE
- Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome
- (2010) Bibhuti B. Mishra et al. CELLULAR MICROBIOLOGY
- Dominant Role of the sst1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts
- (2009) Alexander V. Pichugin et al. AMERICAN JOURNAL OF PATHOLOGY
- Cell-Mediated Immune Responses in Tuberculosis
- (2009) Andrea M. Cooper Annual Review of Immunology
- The protective role of antibody responses duringMycobacterium tuberculosisinfection
- (2009) F. Abebe et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
- (2009) Clifton E. Barry et al. NATURE REVIEWS MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started